Allison R Mackey1, Andrea M L Bussé2, Hans L J Hoeve2, André Goedegebure2, Gwen Carr3, Huibert J Simonsz2, Inger M Uhlén1. 1. CLINTEC, Karolinska Institutet, Stockholm, Sweden. 2. Department of Otorhinolaryngology and Head and Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands. 3. Early Hearing Detection, Intervention and Family Centered Practice, London, UK.
Abstract
OBJECTIVES: To assess the performance of newborn hearing screening (NHS) programmes, through selected quality measures and their relationship to protocol design. DESIGN: NHS coverage, referral, follow-up and detection rates were aggregated. Referral rates were compared to age at screening step 1, number of steps, and test method: OAE or aABR. STUDY SAMPLE: A questionnaire on existing hearing screening was completed by experts from countries in Europe, plus Russia, Malawi, Rwanda, India and China. RESULTS: Out of 47 countries or regions, NHS coverage rates were reported from 26, referral rates from 23, follow up from 12 and detection rates from 13. Median coverage rate for step 1 was 96%. Referral rate from step 1 was 6-22% where screening may be performed <24 h from birth, 2-15% for >24 h, and 4% for >72 h. Referral rates to diagnostic assessment averaged 2.1% after one to two steps using OAE only, 1.7% after two steps including aABR, and 0.8% after three to four steps including aABR. Median detection rate for bilateral permanent hearing impairment ≥40dB was 1 per 1000 infants. CONCLUSION: Referral rates were related to age, test method and number of screening steps. Quality measures were not available for many NHS programmes.
OBJECTIVES: To assess the performance of newborn hearing screening (NHS) programmes, through selected quality measures and their relationship to protocol design. DESIGN: NHS coverage, referral, follow-up and detection rates were aggregated. Referral rates were compared to age at screening step 1, number of steps, and test method: OAE or aABR. STUDY SAMPLE: A questionnaire on existing hearing screening was completed by experts from countries in Europe, plus Russia, Malawi, Rwanda, India and China. RESULTS: Out of 47 countries or regions, NHS coverage rates were reported from 26, referral rates from 23, follow up from 12 and detection rates from 13. Median coverage rate for step 1 was 96%. Referral rate from step 1 was 6-22% where screening may be performed <24 h from birth, 2-15% for >24 h, and 4% for >72 h. Referral rates to diagnostic assessment averaged 2.1% after one to two steps using OAE only, 1.7% after two steps including aABR, and 0.8% after three to four steps including aABR. Median detection rate for bilateral permanent hearing impairment ≥40dB was 1 per 1000 infants. CONCLUSION: Referral rates were related to age, test method and number of screening steps. Quality measures were not available for many NHS programmes.
Authors: Anita Gáborján; Gábor Katona; Miklós Szabó; Béla Muzsik; Marianna Küstel; Mihály Horváth; László Tamás Journal: Eur Arch Otorhinolaryngol Date: 2022-06-29 Impact factor: 3.236
Authors: Jan Kik; Mandy Nordmann; Simona Cainap; Mihai Mara; Daniela Rajka; Monica Ghițiu; Alin Vladescu; Frea Sloot; Anna Horwood; Maria Fronius; Cristina Vladutiu; Huibert Jan Simonsz Journal: Int J Equity Health Date: 2021-12-18
Authors: Allison R Mackey; Andrea M L Bussé; Valeria Del Vecchio; Elina Mäki-Torkko; Inger M Uhlén Journal: BMC Pediatr Date: 2022-08-05 Impact factor: 2.567